TLX completes enrollment in Phase 3 BiPASS study
TLX says it has completed enrollment in its Phase 3 BiPASS study and aligned with the FDA on the NDA pathway.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.